Oxidation of reduced cytosolic nicotinamide adenine dinucleotide by the malate-aspartate shuttle in the K-562 human leukemia cell line
- PMID: 3756905
Oxidation of reduced cytosolic nicotinamide adenine dinucleotide by the malate-aspartate shuttle in the K-562 human leukemia cell line
Abstract
The activity of the malate-aspartate shuttle for the reoxidation of reduced cytosolic nicotinamide adenine dinucleotide (NADH) by mitochondria was studied in a line of human myeloid leukemia cells (K-562). The tumor cells showed mitochondrial reoxidation of cytosolic NADH, as evidenced by the accumulation of pyruvate, when incubated aerobically with L-lactate. The involvement of the respiratory chain in the reoxidation of cytosolic NADH was demonstrated by the action of rotenone, antimycin A, and oligomycin which strongly inhibited the formation of pyruvate from added L-lactate. Moreover, pyruvate production was greatly inhibited by the transaminase inhibitor, aminooxyacetate. Under glycolytic conditions, in the presence of aminooxyacetate, the rate of pyruvate production was also markedly inhibited, the rate of lactate accumulation was stimulated, and at 60 min the cytosolic NADH/nicotinamide adenine dinucleotide (NAD) ratio had increased progressively about 5-fold with respect to untreated cells. The maximal rate of the malate-aspartate shuttle has also been established by addition of arsenite to inhibit mitochondrial oxidation of the pyruvate formed from added L-lactate.
Similar articles
-
Occurrence of the malate-aspartate shuttle in various tumor types.Cancer Res. 1976 Apr;36(4):1392-6. Cancer Res. 1976. PMID: 177206
-
Magnitude of malate-aspartate reduced nicotinamide adenine dinucleotide shuttle activity in intact respiring tumor cells.Cancer Res. 1977 Nov;37(11):4173-81. Cancer Res. 1977. PMID: 198130
-
Oxidation of cytosolic NADH by the malate-aspartate shuttle in MC29 hepatoma cells.Cell Biol Int Rep. 1989 Sep;13(9):739-45. doi: 10.1016/0309-1651(89)90051-9. Cell Biol Int Rep. 1989. PMID: 2805084
-
Neuronal and astrocytic shuttle mechanisms for cytosolic-mitochondrial transfer of reducing equivalents: current evidence and pharmacological tools.Biochem Pharmacol. 2006 Feb 14;71(4):399-407. doi: 10.1016/j.bcp.2005.10.011. Epub 2005 Dec 20. Biochem Pharmacol. 2006. PMID: 16368075 Review.
-
Mitochondrial-cytosolic interactions in cardiac tissue: role of the malate-aspartate cycle in the removal of glycolytic NADH from the cytosol.Symp Soc Exp Biol. 1973;27:241-81. Symp Soc Exp Biol. 1973. PMID: 4358367 Review. No abstract available.
Cited by
-
Targeting aspartate aminotransferase in breast cancer.Breast Cancer Res. 2008;10(5):R84. doi: 10.1186/bcr2154. Epub 2008 Oct 15. Breast Cancer Res. 2008. PMID: 18922152 Free PMC article.
-
Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase.Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14766-71. doi: 10.1073/pnas.97.26.14766. Proc Natl Acad Sci U S A. 2000. PMID: 11121076 Free PMC article.
-
Mitochondrial Genetic and Epigenetic Regulations in Cancer: Therapeutic Potential.Int J Mol Sci. 2022 Jul 18;23(14):7897. doi: 10.3390/ijms23147897. Int J Mol Sci. 2022. PMID: 35887244 Free PMC article. Review.
-
Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment.Pharmaceuticals (Basel). 2023 May 2;16(5):683. doi: 10.3390/ph16050683. Pharmaceuticals (Basel). 2023. PMID: 37242466 Free PMC article.
-
Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2.PLoS One. 2010 Sep 2;5(9):e12520. doi: 10.1371/journal.pone.0012520. PLoS One. 2010. PMID: 20824065 Free PMC article.